 serum alpha-l-fucosidas activ pre-clin clinic stage hepatocellular carcinoma valu serum alpha-l-fucosidas EC marker hepatocellular carcinoma activ patient hepatocellular carcinoma control subject mean serum alpha-l-fucosidas activ patient hepatocellular carcinoma nkat/l patient cirrhosi normal subject nkat/l overlap hepatocellular carcinoma cirrhosi valu enzym diagnost test cirrhot patient hepatocellular carcinoma increas enzym activ detect sampl month tumour serum activ alpha-l-fucosidas refer rang liver transplant hepatocellular carcinoma patient subsequ rise tumour recurr month rise activ ineffect cytotox chemotherapi progress rise serum alpha-l-fucosidas activ alpha-l-fucosidas activ tumour tissu non-tumour tissu cirrhot patient reduct transport tissu increas serum activ patient hepatocellular carcinoma